ANGO logo

AngioDynamics (ANGO) Company Overview

Profile

Full Name:

AngioDynamics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

June 1, 2004

Indexes:

Not included

Description:

AngioDynamics is a medical technology company that specializes in developing innovative products for minimally invasive procedures. They focus on vascular access, oncology, and peripheral vascular disease, providing solutions that improve patient outcomes and enhance healthcare efficiency. Their products include catheters, ports, and other devices for various medical applications.

Key Details

Price

$9.15

Annual Revenue

$303.91 M(-10.28% YoY)

Annual EPS

-$4.59(-245.11% YoY)

Annual ROE

-63.15%

Beta

0.93

Events Calendar

Earnings

Next earnings date:

Apr 4, 2025

Recent quarterly earnings:

Jan 8, 2025

Recent annual earnings:

Jul 16, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 10, 25 HC Wainwright & Co.
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Oct 4, 24 HC Wainwright & Co.
Buy
Oct 4, 24 Canaccord Genuity
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Jul 17, 24 HC Wainwright & Co.
Buy
Jul 17, 24 Canaccord Genuity
Buy
May 22, 24 HC Wainwright & Co.
Buy
Apr 5, 24 Oppenheimer
Outperform
Jan 9, 24 Raymond James
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for AngioDynamics?
  • Does AngioDynamics pay dividends?
  • What sector is AngioDynamics in?
  • What industry is AngioDynamics in?
  • What country is AngioDynamics based in?
  • When did AngioDynamics go public?
  • Is AngioDynamics in the S&P 500?
  • Is AngioDynamics in the NASDAQ 100?
  • Is AngioDynamics in the Dow Jones?
  • When was AngioDynamics's last earnings report?
  • When does AngioDynamics report earnings?
  • Should I buy AngioDynamics stock now?

What is the ticker symbol for AngioDynamics?

The ticker symbol for AngioDynamics is NASDAQ:ANGO

Does AngioDynamics pay dividends?

No, AngioDynamics does not pay dividends

What sector is AngioDynamics in?

AngioDynamics is in the Healthcare sector

What industry is AngioDynamics in?

AngioDynamics is in the Medical Instruments & Supplies industry

What country is AngioDynamics based in?

AngioDynamics is headquartered in United States

When did AngioDynamics go public?

AngioDynamics's initial public offering (IPO) was on June 1, 2004

Is AngioDynamics in the S&P 500?

No, AngioDynamics is not included in the S&P 500 index

Is AngioDynamics in the NASDAQ 100?

No, AngioDynamics is not included in the NASDAQ 100 index

Is AngioDynamics in the Dow Jones?

No, AngioDynamics is not included in the Dow Jones index

When was AngioDynamics's last earnings report?

AngioDynamics's most recent earnings report was on Jan 8, 2025

When does AngioDynamics report earnings?

The next expected earnings date for AngioDynamics is Apr 4, 2025

Should I buy AngioDynamics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions